Our Services
We serve a variety of clients ranging from global pharmaceutical companies to emerging biotech organisations.
We solve our clients’ most challenging issues, including pricing, access, value, portfolio design, launch strategy, partnership strategy, and policy development.
Decisive lift
plug-in teams
-
Launching a new organisation, entering a new market or region
Need to scale rapidly
Limited capability
Uncertainty and financial constraints
Lack of infrastructure
Bringing speed, experience and expertise:
Our team within your team bringing the skill, expertise, and capability you require, when you need it
End-to-end management of pricing and reimbursement processes as a single point of contact across in-scope markets
Broad reach across countries through our Decisive team and intelligent network
Decisive valuate
strategic insight & recommendations
-
valuate delivers:
Global landscape: competition, HTA, disease burden
Asset evaluation: pricing potential and route to market
HTA and access strategy
Go-to-market sequencing, resourcing and JCA planning
Planning for early access and named patient programmes (NPP)
Powerful insights and solutions
Superior insight: strong payer network blended with practical day-to-day experience
Expert analysis: insightful interpretation powered by industry experience and technical rigor, all enabled by technology
Decisive recommendations: informing your most important choices: access strategy, pricing, HTA, phase II-III clinical development
Decisive transform
upskilling teams & organisations
-
Companies building access organisations that are future fit
Established teams preparing for change (JCA)
Teams preparing for launch and negotiation
Departments seeking breakthrough capabilities for access
Access has fundamentally changed
Shaping for success is about creating the right capabilities, mindset, alignment and coordination
Building cutting edge internal capabilities, assessing readiness, sharing insights into industry best practice and enabling internal transformations
Preparing for critical external engagement simulating high stakes discussions with a focus on collaborative negotiation
Decisive evidence
modelling & RWE
-
Early economic modelling through to full cost-effectiveness analysis
Identifying and addressing gaps in evidence
Planning indirect treatment comparisons from ideation to delivery
Building powerful submissions with a clear strategy
RWE generation and modelling
Evidence driving strategy: finding the right evidence and addressing the gaps via our skilled team of writers; conducting systematic literature reviews and crafting compelling value stories told through value dossiers and local submissions
Strategy driving evidence: lifting the evidence base and utilising it to the max
Modelling: utilising health economic modelling from early decision making
Our Capabilities
-
![]()
Primary and secondary research
-
![]()
Health technology assessments
